Research Associate I/II

Richmond, CA
Mar 05, 2021
Required Education
Bachelors Degree
Position Type
Full time

Education: BS or MS in molecular biology, cell biology, biochemistry or a related field

Experience: 1+ years of experience in a laboratory setting, preferably in a molecular/cellular biology laboratory

Travel required: No



• Perform routine molecular biology techniques including DNA isolation, PCR, DNA assembly, transformation, plasmid preparation, WB, SDS-Page, etc.

• Perform routine cellular biology techniques including various cancer cell lines culture, plasmid transfection, stable cell line generation/identification.

• Manage inventory of required materials.

• QC materials required for daily operations.

• Maintain timely documentation of laboratory work.

• Perform other duties as assigned.



• BS or MS in molecular biology, biochemistry, microbiology, cell biology or a related field.

• 1+ years of experience in a laboratory setting, preferably in a molecular and cellular biology laboratory

• Mastery of cell culture/aseptic techniques is desirable.

• Experience with and deep understanding of antibody production is highly desirable.



• Maintain a high degree of ethical standards and trustworthiness.

• Effective organization and implementation of complex and/or group projects.

• Energized by accomplishments and excellence in the workplace.

• Deal with conflict in a direct, positive manner.

• Ability to be flexible and embrace change in work assignments.

• Successful at communicating in both oral and written forms.

• Ability to understand and execute on the company's mission and values.


About ProMab Biotechnologies Inc.

ProMab biotechnologies, Inc., is a leading biotech company on monoclonal antibody development, CAR-T service and research, headquartered in the JOINN innovation park at Richmond, CA. The company has been generating high-quality monoclonal antibodies for over ten years, providing services to major pharmaceutical companies and research institutes. With its proprietary antibody generation platforms, the company is seeking to grow the research and services on human antibody development and CAR-T immunotherapies.